• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

At what point will they TELL US to stay home?





If there is no significant change in quarterly market share, then you know it’s DTC having an impact.

Reps have never been solely accused of spreading the flu so how is this different?
What you need to understand is that if Novo or any other company takes us out of the field, they may realize they don’t need all of us back.
You say to think long term, that’s long term. Be very careful what you wish for.